Total RNA was extracted using either Qiagen
miRNeasy Kit or Ambion
mirVana miRNA Isolation kit according to the manufacturer’s instructions. Extracted RNA (10 ng per reaction) was run in duplicate in Taqman custom designed small RNA Assay and microRNA assays to determine the relative expression of sh5. cDNA was generated using a Taqman MicroRNA reverse transcription kit. Thermocycling was as follows: 16 °C 30 minutes; 42 °C 30 minutes, 85 °C 5 minutes; hold 4 °C. cDNA was diluted 1 in 5 in nuclease-free water, and 5 µl added to each custom Taqman PCR assay set up with Taqman Universal Master Mix No UNG in 20 µl reactions in 96-well plates on the Stratagene Mx3000P. Thermocycling conditions were 50 °C for 2 minutes, 95 °C for 10 minutes, 40 × (95 °C for 15 seconds; 60 °C for 1 minute).
Standard curves were generated using synthetic RNA Oligos for both sh5 and RNU38B (control gene used to normalize sh5). RNA Oligos of known copy number (10
7–10
1) were diluted 10-fold in a background of 10 ng/μl tRNA. Data analysis was performed with Stratagene qPCR MxPro software. Expression of sh5 was determined from the sh5 standard curve and normalized to RNU38B.
Wolstein O., Boyd M., Millington M., Impey H., Boyer J., Howe A., Delebecque F., Cornetta K., Rothe M., Baum C., Nicolson T., Koldej R., Zhang J., Keech N., Camba Colón J., Breton L., Bartlett J., An D.S., Chen I.S., Burke B, & Symonds G.P. (2014). Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor. Molecular Therapy. Methods & Clinical Development, 1, 11-.